Immunovant, Inc. (IMVT)
28.17
-0.24
(-0.84%)
USD |
NASDAQ |
Oct 26, 16:00
28.18
+0.01
(+0.04%)
Pre-Market: 20:00
Immunovant Price : 28.17 for Oct. 26, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 28.46 | 28.50 | 27.62 | 28.17 | 1.195M |
| Oct 23, 2026 | 28.93 | 28.93 | 28.14 | 28.41 | 641437.0 |
| Oct 22, 2026 | 28.09 | 29.12 | 27.98 | 29.10 | 1.157M |
| Oct 21, 2026 | 28.97 | 29.18 | 28.05 | 28.38 | 1.495M |
| Oct 20, 2026 | 27.76 | 29.14 | 27.62 | 28.59 | 1.449M |
| Oct 19, 2026 | 27.12 | 27.84 | 26.52 | 27.62 | 1.375M |
| Oct 16, 2026 | 27.42 | 27.42 | 26.28 | 26.73 | 1.463M |
| Oct 15, 2026 | 28.03 | 28.33 | 27.48 | 27.51 | 1.649M |
| Oct 14, 2026 | 28.46 | 28.79 | 27.83 | 27.90 | 1.774M |
| Oct 13, 2026 | 29.37 | 29.64 | 28.70 | 28.71 | 1.245M |
| Oct 12, 2026 | 30.17 | 30.60 | 28.61 | 29.48 | 2.242M |
| Oct 09, 2026 | 30.25 | 30.64 | 30.06 | 30.47 | 1.495M |
| Oct 08, 2026 | 31.40 | 31.50 | 29.80 | 30.26 | 1.756M |
| Oct 07, 2026 | 31.72 | 32.75 | 31.58 | 32.04 | 1.131M |
| Oct 06, 2026 | 33.51 | 33.51 | 31.36 | 32.11 | 1.674M |
| Oct 05, 2026 | 33.99 | 33.99 | 32.95 | 33.25 | 1.104M |
| Oct 02, 2026 | 34.11 | 34.24 | 33.21 | 33.62 | 1.022M |
| Oct 01, 2026 | 33.56 | 34.60 | 33.30 | 33.65 | 1.672M |
| Sep 30, 2026 | 33.62 | 34.20 | 33.12 | 33.78 | 1.434M |
| Sep 29, 2026 | 33.43 | 33.52 | 32.45 | 33.46 | 1.311M |
| Sep 28, 2026 | 32.93 | 33.77 | 32.65 | 33.49 | 1.229M |
| Sep 25, 2026 | 34.00 | 34.22 | 33.17 | 33.30 | 2.350M |
| Sep 24, 2026 | 34.21 | 34.54 | 33.35 | 34.00 | 1.480M |
| Sep 23, 2026 | 36.35 | 37.00 | 33.60 | 34.54 | 3.653M |
| Sep 22, 2026 | 37.38 | 38.15 | 36.84 | 37.29 | 2.255M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Roivant Sciences Ltd. | 36.05 |
| Moderna, Inc. | 198.85 |
| Altimmune, Inc. | 2.05 |
| Vertex Pharmaceuticals, Inc. | 517.49 |
| First Tracks Biotherapeutics, Inc. | 43.48 |
Price Related Metrics
| Price to Book Value | 7.901 |
| Earnings Yield | -9.97% |
| Market Cap | 5.810B |